COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 698: Articles 6971-6980  | Next

Accurate and Fast Clade Assignment via Deep Learning and Frequency Chaos Game Representation
Avila Cartes, J., Anand, S., Ciccolella, S., Bonizzoni, P., Della Vedova, G.
10.1101/2022.06.13.495912 — Posted: 2022-06-13
An attenuated vaccinia vaccine encoding the SARS-CoV-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human ACE2 transgenic mice from SARS-CoV-2 and its variants
Ishigaki, H., Yasui, F., Nakayama, M., Endo, A., Yamamoto, N., Yamaji, K., Nguyen, C. T., Kitagawa, Y., Sanada, T., Honda, T., Munakata, T., Higa, M., Toyama, S., Kono, R., Takagi, A., Matsumoto, Y., Hayashi, K., Shiohara, M., Ishii, K., Saeki, Y., Itoh, Y., Kohara, M.
10.1101/2022.06.12.495779 — Posted: 2022-06-13
Two ligand-binding sites on SARS-CoV-2 non-structural protein 1 revealed by fragment-based x-ray screening
Ma, S., Damfo, S., Lou, J., Pinotsis, N., Bowler, M. W., Haider, S., Kozielski, F. G.
10.1101/2022.06.12.495816 — Posted: 2022-06-13
Media coverage and speculation about the impact of the COVID-19 pandemic on suicide: A content analysis of UK news.
Marzano, L., Hawley, M., Fraser, L., Lainez, Y., Marsh, J., Hawton, K.
10.1101/2022.06.10.22275998 — Posted: 2022-06-13
Online dashboards for SARS-CoV-2 wastewater data need standard best practices: an environmental health communication agenda
Naughton, C. C., Holm, R. H., James, B. P., Smith, T. R.
10.1101/2022.06.08.22276124 — Posted: 2022-06-13
SARS-CoV-2 RNA levels in Scotland's wastewater
Scorza, L. C. T., Cameron, G. J., Murray-Williams, R., Findlay, D., Bolland, J., Cerghizan, B., Campbell, K., Thomson, D., Corbishley, A., Gally, D. L., Fitzgerald, S., Low, A., McAteer, S., Roberts, A. M. I., Fang, Z., Mayer, C.-D., Frantsuzova, A., Baby, S. V., Zielinski, T., Millar, A. J.
10.1101/2022.06.08.22276093 — Posted: 2022-06-13
SARS-CoV-2 type I Interferon modulation by non structural proteins 1 and 2
Flamand, L., Lacasse, E., Dubuc, I., Allaeys, I., Gudimard, L., Gravel, A., Boilard, E.
10.1101/2022.06.09.495586 — Posted: 2022-06-13
Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Naggie, S.
10.1101/2022.06.10.22276252 — Posted: 2022-06-12
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
Ullah, I., Beaudoin-Bussieres, G., Symmes, K., Cloutier, M., Ducas, E., Tauzin, A., Laumaea, A., Begin, P., Mothes, W., Bazin, R., Finzi, A., Uchil, P. D.
10.1101/2022.06.10.495677 — Posted: 2022-06-12
Hybrid immunity shifts the Fc-effector quality of SARS-CoV-2 mRNA vaccine-induced immunity
Bowman, K. A., Stein, D., Shin, S., Ferbas, K. G., Tobin, N., Mann, C., Fischinger, S., Ollmann Saphire, E., Lauffenberger, D., Rimoin, A., Aldrovandi, G., Alter, G.
10.1101/2022.06.10.495727 — Posted: 2022-06-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).